rxstat › Shortages › Insulin Glulisine

Insulin Glulisine shortage status

No current shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Insulin Glulisine has no current shortage reported in Canada. It has been in shortage before; the history is below.
Products affected
0 / 3
Reports on file
16

Reports by product

Resolved
APIDRA
100UNIT · SOLUTION · SANOFI-AVENTIS CANADA INC
DIN 02294346 · ended Jun 12, 2026 · Other (Please describe in comments)
Resolved
APIDRA
100UNIT · SOLUTION · SANOFI-AVENTIS CANADA INC
DIN 02279479 · ended May 29, 2026 · Other (Please describe in comments)
Resolved
APIDRA
100UNIT · SOLUTION · SANOFI-AVENTIS CANADA INC
DIN 02294346 · ended Jan 30, 2026 · Other (Please describe in comments)
Resolved
APIDRA
100UNIT · SOLUTION · SANOFI-AVENTIS CANADA INC
DIN 02279479 · ended Jan 28, 2026 · Other (Please describe in comments)
Resolved
APIDRA
100UNIT · SOLUTION · SANOFI-AVENTIS CANADA INC
DIN 02279460 · ended Jul 11, 2023 · Other (Please describe in comments)
Resolved
APIDRA
100UNIT · SOLUTION · SANOFI-AVENTIS CANADA INC
DIN 02279479 · ended Jul 11, 2023 · Other (Please describe in comments)
Resolved
APIDRA
100UNIT · SOLUTION · SANOFI-AVENTIS CANADA INC
DIN 02294346 · ended Jul 11, 2023 · Other (Please describe in comments)
Resolved
APIDRA
100UNIT · SOLUTION · SANOFI-AVENTIS CANADA INC
DIN 02279479 · ended Oct 11, 2022 · Demand increase for the drug.
Resolved
APIDRA
100UNIT · SOLUTION · SANOFI-AVENTIS CANADA INC
DIN 02294346 · ended Sep 23, 2022 · Delay in shipping of the drug.
Resolved
APIDRA
100UNIT · SOLUTION · SANOFI-AVENTIS CANADA INC
DIN 02279479 · ended Sep 13, 2022 · Demand increase for the drug.
Resolved
APIDRA
100UNIT · SOLUTION · SANOFI-AVENTIS CANADA INC
DIN 02294346 · ended Jun 1, 2022 · Delay in shipping of the drug.
Resolved
APIDRA
100UNIT · SOLUTION · SANOFI-AVENTIS CANADA INC
DIN 02294346 · ended Feb 1, 2022 · Delay in shipping of the drug.

Showing 12 of 16 reports. All reports are on file with Health Canada.

What's happening

There are no active shortage reports for Insulin Glulisine. Health Canada has 16 historical reports on file for this drug, so supply has been disrupted before; the change log below shows the history.

Insulin Glulisine is classified under “INSULINS AND ANALOGUES” (ATC A10AB).

Recent changes

Common questions

When will Insulin Glulisine be back in stock in Canada?

Insulin Glulisine has no active shortage; supply is normal per Health Canada reports.

Why is Insulin Glulisine in shortage?

It isn't currently. Past reports and their reasons are listed above.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (insulins and analogues)

Partial shortageInsulin Glargine1 of 6 reported products affected · est. return Jul 31, 2026No current shortageInsulinNo current shortageInsulin AspartDiscontinuedInsulin Detemir0 of 2 reported products affectedNo current shortageInsulin Injection Human BiosyntheticDiscontinuedInsulin Injection Pork0 of 1 reported products affected

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.